milker's nodule
milker's nodule
Explore linked clinical trials. Standard reference: MONDO:000585043 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Assess the Safety and Immunogenicity of TPOXX® When Administered Orally for 28 Days With JYNNEOS | DNA Virus Infections, Infections, milker's nodule, smallpox, viral infectious disease | Active, not recruiting | Phase 2 | 2026-09-14 | NCT04957485 | |
| Evaluation of Effectiveness and Safety of LC16m8 Mpox Vaccine in the Democratic Republic of Congo (DRC) | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Recruiting | Not stated | 2026-08-31 | NCT07093489 | |
| New York City Observational Study of Mpox Immunity | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Enrolling by invitation | Not stated | 2026-08-27 | NCT05654883 | |
| Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076) | Adnexal Diseases, DNA Virus Infections, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Infections, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, fallopian tube cancer, fallopian tube disorder, fallopian tube neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, milker's nodule, neoplasm, ovarian cancer, ovarian disorder, primary peritoneal carcinoma, vaccinia, viral infectious disease | Recruiting | Phase 3 | 2026-08-26 | NCT05281471 | |
| Smart Analysis and Decision-Making for Emerging Infectious Diseases | Alphavirus infectious disease, COVID-19, Communicable Diseases, Emerging, Coronaviridae Infections, DNA Virus Infections, Disease Attributes, Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, avian influenza, bird disease, chikungunya, dengue disease, infectious disease, influenza, lung disorder, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, pneumonia, respiratory system disorder, respiratory tract infectious disorder, rodent disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease, viral pneumonia | Enrolling by invitation | Not applicable | 2026-08-19 | NCT07678619 | |
| Smallpox Vaccine for Mpox Post-Exposure Prophylaxis: A Cluster RCT | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Active, not recruiting | Phase 4 | 2026-08-12 | NCT05745987 | |
| A Randomized Clinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA-based Mpox Vaccine Candidate in Africa | DNA Virus Infections, Infections, Orthopoxvirus Infection, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, smallpox, viral infectious disease | Recruiting | Phase 2 | 2026-08-11 | NCT07379580 | |
| IDOV-Immune for Advanced Solid Tumors | Adnexal Diseases, Cancer of the Uterine Cervix, DNA Virus Infections, Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Head and Neck Neoplasms, Infections, Liver Neoplasms, Male Urogenital Diseases, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, adenocarcinoma, adrenal gland cancer, adrenal gland disorder, benign urinary system neoplasm, breast cancer, breast disorder, breast neoplasm, carcinoma, cervix disorder, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, epithelial neoplasm, esophageal cancer, esophageal disorder, female reproductive system disorder, female reproductive system neoplasm, gastric cancer, gastric neoplasm, gonadal disorder, hepatocellular carcinoma, intestinal disorder, kidney cancer, kidney disorder, liver disorder, lung cancer, lung disorder, lung neoplasm, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, melanocytic neoplasm, melanoma, milker's nodule, neoplasm, neuroendocrine neoplasm, ovarian cancer, ovarian disorder, pancreas disorder, pancreatic neoplasm, primitive neuroectodermal tumor, prostate cancer, prostate disorder, rectal disorder, renal cell carcinoma, respiratory system disorder, respiratory tract neoplasm, sarcoma, skin disorder, skin neoplasm, stomach disorder, urinary bladder cancer, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder, uterine disorder, vaccinia, viral infectious disease | Recruiting | Phase 1 | 2026-08-05 | NCT06910657 | |
| Characterization of Vaccine-induced Responses Against Monkeypox (MoVIHvax) An Observational Prospective Cohort Study | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Recruiting | Not stated | 2026-07-07 | NCT05562323 | |
| Validation of SDS-EDTA-Treated Chromatography Paper Strips for Mpox Sampling and Transport in DRC | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Recruiting | Not stated | 2026-06-11 | NCT07634081 | |
| Mpox Biology, Outcome, Transmission and Epidemiology - Tracking the Immune Response After mpoX vaCcination (MBOTE-TRAXX): Clinical Study to Monitor the Immunological Response Following Mpox Vaccination in the City of Kinshasa, Democratic Republic of the Congo | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Active, not recruiting | Phase 4 | 2026-06-11 | NCT07499739 | |
| Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer | DNA Virus Infections, Infections, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, carcinoma, epithelial neoplasm, lung disorder, lung neoplasm, milker's nodule, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm, vaccinia, viral infectious disease | Recruiting | Phase 2 | 2026-06-04 | NCT06463665 | |
| Assessment of the Efficacy and Safety of Tecovirimat in Patients With Monkeypox Virus Disease | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Active, not recruiting | Phase 3 | 2026-05-26 | NCT05597735 | |
| An Immunogenicity and Safety Trial of MVA-BN in Adults Living With HIV for the Prevention of Mpox Infection, in Kinshasa, DRC | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Active, not recruiting | Phase 2 | 2026-05-19 | NCT06839989 | |
| Assessment of Immune Memory - Humoral and Cellular - in mPOX-infected Patients : an Ancillary Study of the ANRS0258s MOSAIC Cohort | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Not yet recruiting | Not applicable | 2026-05-18 | NCT07592429 | |
| VA-005 Clinical Outcomes of VIGIV Treatment of Smallpox Vaccination Complications or Vaccinia Infection | DNA Virus Infections, Infections, milker's nodule, smallpox, viral infectious disease | Enrolling by invitation | Not stated | 2026-05-12 | NCT01374984 | |
| Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, smallpox, viral infectious disease | Active, not recruiting | Phase 3 | 2026-04-29 | NCT06844487 | |
| Understanding MPXV Viral Clearance, Transmission Dynamics, and Mpox Vaccine Effectiveness in West Africa : Guinea | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Not yet recruiting | Not stated | 2026-04-16 | NCT07534267 | |
| Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Active, not recruiting | Phase 2 | 2026-04-08 | NCT07199569 | |
| Prospective Study for the FOLLOW-UP of Human Monkeypox Cases and Smallpox Vaccinees at Risk | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Recruiting | Not stated | 2026-03-19 | NCT05879965 | |
| Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Pancreatic Cancer | DNA Virus Infections, Digestive System Diseases, Digestive System Neoplasms, Infections, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, milker's nodule, neoplasm, pancreas disorder, pancreatic neoplasm, vaccinia, viral infectious disease | Recruiting | Phase 2 | 2026-02-27 | NCT07006077 | |
| Phase 3 Maternal Safety & Immunogenicity Trial of MVA-BN® in DRC | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, smallpox, viral infectious disease | Active, not recruiting | Phase 3 | 2026-01-30 | NCT06844500 | |
| Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After Single/Multiple Doses. | DNA Virus Infections, Infections, cowpox, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, smallpox, viral infectious disease | Recruiting | Phase 1 | 2026-01-29 | NCT07377175 | |
| Prospective Follow-up After MVA-BN Booster Vaccination | DNA Virus Infections, Infections, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, rodent disease, viral infectious disease | Not yet recruiting | Not stated | 2026-01-20 | NCT07342829 | |
| Neutralizing Power of Serum Antibodies - 2 | COVID-19, Coronaviridae Infections, DNA Virus Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, milker's nodule, monkeypox, non-human animal disease, non-human primate disease, pneumonia, respiratory system disorder, respiratory tract infectious disorder, rodent disease, viral infectious disease, viral pneumonia | Recruiting | Not applicable | 2025-12-19 | NCT07085611 |